IMTM Overview

  • Founded
  • 1996
Founded
  • Status
  • Out of Business
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Out of Business

IMTM General Information

Description

Developer of drugs designed to treat diseases related to immune dysfunction. The company's drugs use peptidase-based immunmodulation and offers services for clinical and experimental medicine using latest technologies in molecular and cell biology, enabling clinicians to get a comprehensive set of in silico, in vitro and in vivo methods essential for the discovery, optimization and assessment of drug candidates.

Contact Information

Website
www.imtm.de
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Services
Primary Office
  • Leipziger Straße 44
  • 39120 Magdeburg
  • Germany
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IMTM Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Apr-2018 Completed Out of Business
2. Grant Completed Generating Revenue
1. Later Stage VC Completed Generating Revenue
To view IMTM’s complete valuation and funding history, request access »

IMTM Executive Team (4)

Name Title Board Seat Contact Info
Siegfried Ansorge Ph.D Founder & Managing Director
Ute Bank Ph.D Head, Immunopharm
You’re viewing 2 of 4 executive team members. Get the full list »

IMTM Board Members (2)

Name Representing Role Since
Ernst-Günter Afting Ph.D Self Chairman 000 0000
You’re viewing 1 of 2 board members. Get the full list »

IMTM Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial